Dr. Del Rivero’s areas of expertise include endocrine oncology and rare tumors. She is the Principal Investigator of the Natural History Study for Neuroendocrine Neoplasm and Adrenocortical Cancer to provide the basis of further development of therapeutic interventions, prevention/screening guidelines, endpoints for future clinical trials, and patient reported outcome measures. Dr. Del Rivero’s current efforts is the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroentero pancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma.